Bladder device gets Long-Term safety check

NCT ID NCT07144813

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how safe and effective the Neuspera Sacral Neuromodulation (SNM) system is over time for people with sudden, strong urges to urinate (urinary urgency incontinence). About 116 people who already have the device implanted will be followed to see if their symptoms improve by at least half. The goal is to confirm the device works well for long-term bladder control.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 116 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects in the SANS-UUI Phase I or Phase II study Exclusion Criteria: * None

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Urinary urgency incontinence are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Adult & Pediatric Urology P.C

    ACTIVE_NOT_RECRUITING

    Omaha, Nebraska, 68114, United States

  • Florida Urology Partners

    ACTIVE_NOT_RECRUITING

    Tampa, Florida, 33615, United States

  • Genesis Healthcare Partners

    ACTIVE_NOT_RECRUITING

    San Diego, California, 92123, United States

  • Indiana University, School of Medicine

    ACTIVE_NOT_RECRUITING

    Indianapolis, Indiana, 46202, United States

  • Kaiser Permanente Point Loma MOB

    ACTIVE_NOT_RECRUITING

    San Diego, California, 92110, United States

  • MetroHealth System,

    ACTIVE_NOT_RECRUITING

    Cleveland, Ohio, 44109, United States

  • Minnesota Urology

    ACTIVE_NOT_RECRUITING

    Woodbury, Minnesota, 55125, United States

  • Ochsner Medical

    ACTIVE_NOT_RECRUITING

    New Orleans, Louisiana, 70121, United States

  • Premier Medical Group,

    ACTIVE_NOT_RECRUITING

    Poughkeepsie, New York, 12603, United States

  • Southern Urogynecology,

    ACTIVE_NOT_RECRUITING

    West Columbia, South Carolina, 29169, United States

  • Specialty Research of St. Louis

    ACTIVE_NOT_RECRUITING

    St Louis, Missouri, 63141, United States

  • The Institute for Female Pelvic Medicine and Reconstructive Surgery,

    ACTIVE_NOT_RECRUITING

    North Wales, Pennsylvania, 19454, United States

  • UCNT Dallas,

    ACTIVE_NOT_RECRUITING

    Dallas, Texas, 75231, United States

  • University of Kansas Medical Center,

    ACTIVE_NOT_RECRUITING

    Kansas City, Kansas, 66160, United States

  • University of Louisville Health System,

    ACTIVE_NOT_RECRUITING

    Louisville, Kentucky, 40202, United States

  • University of Michigan Health

    ACTIVE_NOT_RECRUITING

    Wyoming, Michigan, 49519, United States

  • Urology Austin,

    RECRUITING

    Austin, Texas, 78759, United States

  • Virginia Mason Medical Center,

    ACTIVE_NOT_RECRUITING

    Seattle, Washington, 98101, United States

  • Women's Health Advantage,

    ACTIVE_NOT_RECRUITING

    Fort Wayne, Indiana, 46825, United States

  • Women's Healthcare Associates,

    ACTIVE_NOT_RECRUITING

    Portland, Oregon, 97225, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.